Criminal Justice (Drug Policy)

HB 2057 establishes a 7% tax on retail medical marijuana sales in Oklahoma, collected at the point of sale. Tax revenue is allocated annually starting July 2026: $65 million is divided between the State Public Common School Building Fund (59.23%), the Oklahoma Medical Marijuana Authority (34.62%), drug and alcohol rehabilitation programs (5%), and the Trauma Care Assistance Revolving Fund (1.15%). Any surplus tax collections go to the General Revenue Fund. The bill also requires medical marijuana businesses to pay taxes or face permanent license revocation.

SB 574 expands the types of opioid-related projects eligible for state grant funding by allowing the Attorney General to allocate funds toward new prevention, treatment, and recovery initiatives. It directly affects state agencies and community organizations receiving opioid grants by broadening allowable uses beyond current restrictions. The bill authorizes the Attorney General to use grant funds for specific, previously ineligible activities, such as community-based support programs. This policy change modifies how opioid grant funds are distributed without altering the grant application process.